Japan’s GINKAN Inc has raised a $2.6 million Series A funding round led by MTG Ventures, Inc while South Korean chaebol SK Group has acquired a 25 per cent stake in Vietnam’s Imexpharm Corporation.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in